Contract manufacturer qualified six peptide actives in one coordinated batch for its house range
A contract manufacturer was expanding its stock peptide-serum platform and needed to qualify six actives across several claim categories at once — firming, expression-line, eye-area, and brightening — rather than running six separate sourcing exercises. A single coordinated qualification cycle cleared all six in 12 weeks.
Published May 18, 2026 · Anonymized customer story
Inquiry → six actives qualified
12 weeks (single cycle)
Actives qualified at once
6 · across 4 claim categories
Forecast / documentation structure
1 (shared across clients)
Claim categories added
Firming · expression-line · eye-area · brightening
Challenge
The manufacturer ran a catalogue of stock cosmetic bases its brand-owner clients customised, and demand had outgrown the two peptides on its approved-actives list. The Director of Formulation wanted to qualify six actives in one coordinated cycle — a Matrixyl-family matrikine and Tripeptide-10 Citrulline (firming), SYN-AKE (expression-line), Eyeseryl and Dipeptide-2 (eye-area), and Nonapeptide-1 (brightening) — each against the relevant house base, with documentation structured so any brand-owner client could pull a per-active packet for their own destination-market notification. Six separate sourcing-and-qualification exercises would have consumed a quarter; the goal was a single supplier, a single forecast, and one documentation structure.
Approach
Pepoderma quoted all six actives against a single 12-month forecast, with the required INCI and client-document scope defined before the work. Each active mapped to a handling profile and the finishing brand retained responsibility for carrier validation and eye-contour tolerance. The agreed lot documents—not a generic fixed bundle—were then tied to the applicable batches.
Outcome
All six actives cleared the manufacturer's qualification inside a single 12-week cycle, drawing on one forecast and one documentation structure. The manufacturer added all six to its approved-actives list and could offer brand-owner clients stock bases across firming, expression-line, eye-area, and brightening claim categories without re-qualifying per client. The per-active packet structure meant the first three clients to build on the new bases each pulled their own destination-market documentation without the manufacturer's team rewriting the same data, and subsequent reorders ran against the standing forecast.
“Six actives, four claim categories, one qualification cycle. Batching the work by mechanism and getting one documentation structure I could hand to any client — that is what turned a quarter of sourcing into twelve weeks, and it is why my approved-actives list finally matches what my clients are asking for.”